|
Volumn 3, Issue 3, 2015, Pages e113-
|
Ebola vaccines: An uncertain future?
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADENOVIRUS VECTOR;
BRINCIDOFOVIR;
CELL SURFACE PROTEIN;
EBOLA VACCINE;
EBOLA VIRUS;
GOVERNMENT;
IMMUNOGENICITY;
LETTER;
PHASE 1 CLINICAL TRIAL (TOPIC);
PHASE 3 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
PUBLIC HEALTH;
SCALE UP;
SMALLPOX;
VESICULOVIRUS;
EBOLAVIRUS;
HEMORRHAGIC FEVER, EBOLA;
HUMAN;
IMMUNOLOGY;
VIROLOGY;
EBOLA VACCINES;
EBOLAVIRUS;
HEMORRHAGIC FEVER, EBOLA;
HUMANS;
|
EID: 84925337680
PISSN: None
EISSN: 2214109X
Source Type: Journal
DOI: 10.1016/S2214-109X(15)70083-5 Document Type: Editorial |
Times cited : (3)
|
References (0)
|